SAN FRANCISCO, April 25, 2018 -- Hagens Berman Sobol Shapiro LLP reminds investors in Henry Schein, Inc. (NASDAQ:HSIC) of the May 7, 2018 Lead Plaintiff deadline in the securities class action pending in the United States District Court for the Eastern District of New York. If you purchased or otherwise acquired Henry Schein securities between March 7, 2013 and February 12, 2018 and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more information visit:
https://www.hbsslaw.com/cases/HSIC
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing
On February 12, 2018, the United States Federal Trade Commission (“FTC”) announced it sued Henry Schein and two other dental supply companies.
The FTC charges the Company: (a) illegally restrained price competition for dental products in the United States; (b) distorted prices and undermined the ability of independent dentists to obtain lower prices and discounts for dental products; (c) deprived independent dentists of the benefits of vigorous price and service competition among full-service, national dental distributors; (d) unreasonably reduced output of dental products to dental buying groups; and (e) eliminated or reduced the competitive bidding process for sales to these buying groups.
This news drove the price of Henry Schein shares down $4.79, or about 6.6%, to close at $67.39 on February 13, 2018.
“Henry Schein investors have suffered enormous losses,” said Hagens Berman partner Reed Kathrein. “We’re focused on Defendants’ statements to investors about the Company’s revenues and purported industry competition.”
Whistleblowers: Persons with non-public information regarding Henry Schein should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with 70+ attorneys in 11 offices across the country. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes can be found at www.hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact:
Reed Kathrein, 510-725-3000


Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO
Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership
Oil and LNG Tankers Turn Back as Strait of Hormuz Security Risks Escalate
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO
Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft
Chinese Chip Stocks Jump as Apple Reportedly Tests CXMT Memory Chips for China Devices
Bernstein Names IAG, Ryanair as Top European Airline Stocks Ahead of Earnings
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside
Mizuho’s Top U.S. Industrials Stocks: Why Corteva and Stanley Black & Decker Stand Out 



